跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
MAEVE
Authorized
STANDARD
MAEVE
glenmark pharmaceuticals canada inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
6137d228e5b6afd6
Company
glenmark pharmaceuticals canada inc.
Type
Standard
Approval Details
Approval Id
6137d228e5b6afd6
Drug Approval Canada Name
MAEVE
Product Name
MAEVE
Status
Marketed
Status Date
2022-12-16
Original Market Date
2022-12-16
Din
02458683
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
68:12.00
Atc Original
G03AC01 NORETHISTERONE
Atc Name
g 03 ac 01
Aig Number
0106372001
Company Name
glenmark pharmaceuticals canada inc.
Company Address
1600 Steeles Ave. W., Suite 407, Concord, Ontario, Canada, L4K 4M2
Active Ingredients
NORETHINDRONE
0.35 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
6137d228e5b6afd6
Type
Standard
Back to Health Canada Approvals
MAEVE - Health Canada Drug Approval Details